Inherited Cardiac Conditions & Genetic Testing

Genetic testing is an important and necessary aspect of the management of families with cardiac genetic conditions. Here is the lastest research.

October 13, 2021
Review
Open Access

Genetic Testing in Patients with Hypertrophic Cardiomyopathy.

International Journal of Molecular Sciences
Jiri BonaventuraJosef Veselka
October 7, 2021
Review

Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

The Cochrane Database of Systematic Reviews
Nadeem QureshiJo Leonardi-Bee
October 2, 2021
Open Access

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy.

Molecular Genetics & Genomic Medicine
Elena V FilatovaMaria I Shadrina
September 29, 2021
Preprint
Open Access

Systemic and Genetic Risk Factors for Reticular Macular Disease and Soft Drusen in Age- Related Macular Degeneration

MedRxiv : the Preprint Server for Health Sciences
R. J. ThomsonR THEODORE SMITH
September 24, 2021
Open Access

LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients.

BMC Nephrology
Monika BuraczynskaAndrzej Ksiazek
September 20, 2021
Open Access

Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.

Frontiers in Pediatrics
Alina Schultze-BerndtSabine Klaassen
September 17, 2021

[Significance of circulating tumor cell monitoring in targeted therapy for gastrointestinal stromal tumors].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
J B FanJ W Zhu
September 16, 2021
Case Report
Open Access

Acute Myocardial Infarction Followed by Cerebral Hemorrhagic Infarction in Polycythemia Vera: Case Report and Literature Review.

Frontiers in Cardiovascular Medicine
XiangSen ShaoFei Xiao
September 14, 2021

Preclinical short QT syndrome models: studying the phenotype and drug-screening.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Xuehui FanIbrahim El-Battrawy
September 9, 2021
Review

Role of Genetics in Preventive Cardiology: Focused on Dyslipidemia.

Korean Circulation Journal
Sang-Hak Lee
September 5, 2021

Novel insertion mutation (Arg1822_Glu1823dup) in MYH6 coiled-coil domain causing familial atrial septal defect.

European Journal of Medical Genetics
Shufang HuangYu Xia
September 3, 2021
Review

Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.

Biochemical Genetics
Eskandar TaghizadehSeyed Mohammad Gheibihayat

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved
/feed-previews/inherited-cardiac-conditions-genetic/1d0554b9-c0b9-41a2-8fda-0dbf0ea91982